Venus MedTech (HangZhou) Inc.

15 articles with Venus MedTech (HangZhou) Inc.

• Venus Medtech Appoints Professor Martin B. Leon as Global Principal Investigator of Its New-Generation RDN System

  7/28/2021

  On July 27, 2021, Venus Medtech Inc., a leading provider of comprehensive interventional heart valve therapy solutions in China, and its controlling subsidiary Renaly Ltd., announced that Professor Martin B. Leon, MD, a pioneer in the field of interventional cardiovascular devices, has been appointed as the Global Principal Investigator for its new-generation renal artery denervation system.

• Venus Medtech to Partner with Pi-Cardia to Bring its Leaflex(TM) Aortic Valve Technology to China

  7/14/2020

  Venus Medtech Inc., the leading transcatheter heart valve medical device player in China, and Pi-Cardia Ltd., a global leader in the development of non-implant catheter-based solutions for treating heart valve calcification, announced a collaboration to bring Pi-Cardia's Leaflex™ technology to China.

• Venus Medtech and Opus Medical Therapies, LLC Announce Partnership for Transcatheter Mitral Valve Replacement (TMVR) and Transcatheter Tricuspid Valve Replacement (TTVR) in Greater China Market

  5/2/2020

  Venus Medtech Inc., the leading Chinese transcatheter heart valve company and Opus Medical Therapies, LLC, a medical device company focused on developing transcatheter mitral and tricuspid valve replacement products for patients undergoing mitral and tricuspid valve disease, announced a partnership agreement to develop, manufacture and sell these TMVR and TTVR products in Greater China.

• Venus Medtech Announces the Addition of Two Cardiovascular Experts to Their Advisory Team

  1/20/2020

  The leading transcatheter heart valve medical device player in China - Venus Medtech Inc., is pleased to announce the appointment of two new cardiovascular experts to its advisory team.

• Venus Medtech Launches Global Advisor Board to Target for International Market

  9/24/2018

  Venus Medtech has retained four world-renowned experts specialized in interventional cardiovascular to form a Global Advisory Board.

• Venus Medtech Enters North American Market

  6/14/2018

  First Clinical Implantation of Transcatheter Pulmonary Valve VenusP-Valve in North America was Successfully Performed in Vancouver, Canada

• Venus Medtech Release: First Successful Clinical Implantation of Transcatheter Pulmonary Valve VenusP-Valve was Successfully Completed in Brazil

  12/22/2017

  On December 19, 2017, local time, 4 clinical implantations of transcatheter pulmonary valve VenusP-Valve were successfully completed in Brazil by Professor Carlos Pedra from Dante Pazzanese Institute of Cardiovascular Technology in Sao Paulo, Brazil.

• Venus Medtech Release: China Successfully Completes the Country's First Human Implantation of a Retrievable Transcatheter Aortic Valve

  11/28/2017

  - The success of the procedure unleashes a new era for retrievable interventional cardiac valve technology in China   [28-November-2017]   HANGZHOU, China, Nov. 28, 2017 /PRNewswire/ -- The first human implantation of the VenusA Plus retrievable valve system was completed successfully at the Second Affiliated Hospital of Zhejiang University School of Medicine (SA

• Venus MedTech Acquires U.S. Company InterValve To Create A Systematic TAVR Treatment And Strengthen Global Expansion

  6/14/2017

• CFDA Approves Venus MedTech's Minimally Invasive Aortic Valve Implant

  5/1/2017

• Venus MedTech's TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In China

  4/28/2017

• Hangzhou's Venus MedTech Forms CV Device Partnership With Keystone Heart

  3/6/2017

• Keystone Heart And Venus MedTech Announce Partnership For Cerebral Embolic Protection With Transcatheter Heart Valve Systems (TAVR) In China And Key Asian Markets

  3/2/2017

• The Successful Worldwide First In Human Implantation Of An Innovative Aortic Valve From Colibri Heart Valve, LLC And Venus MedTech With Disruptive "Dry Tissue" Technology Conducted

  10/28/2016

• Venus MedTech's Transcatheter Pulmonary Valve Debuts In Europe, Marking The Start Of Global Clinical Trial

  9/19/2016